Ingevity opened lower at $63.01, compared with its previous close of $63.24. In the last trading session, the stock traded between $61.92 and $63.44. It showed a downward intraday trend.
An investment of $100 made 5 years ago in Ingevity is now worth
$ 75.75
Resulting in a loss of
$ 24.25 (24.25%)
Note: Past profits do not guarantee future returns.
Rating from 1 Analysts
Today's Change
$-1.25 (-1.98%)
Day High
$63.44
Day Low
$61.92
Day Open
$63.01
Prev Close
$63.24
Volume
2,00,353
1W Return
-15.85%
1M Return
-10.17%
3M Return
-20.34%
6M Return
-16.72%
1Y Return
25.16%
Market Cap ($ Mn)
2,094
PE Ratio
99.19
PB Ratio
51.05
PEG Ratio
-
ROE
-104.62%
ROCE
-4.47%
EPS (TTM)
$1.45
1 Week
-15.85%
1 Month
-10.17%
3 Months
-20.34%
6 Months
-16.72%
9 Months
-17.25%
Ingevity Q3FY26 Results: Adjusted EBITDA margin expands 230 bps to 35.4%
Adjusted EBITDA margin expanded 230 bps to 35.4% in Q3FY26. Reported sales fell 8% YoY to $305 million; up 2% excluding divestitures. Full-year adjusted EBITDA outlook narrowed to $385M-$395M, midpoint unchanged. Repurchased $39 million in shares, bringing YTD total to $125 million. Filtration segment secured new contracts for PFAS removal and biogas purification.
7 days agoIngevity included in TIME America’s Best Companies 2026 list
Ingevity Corporation has been recognized as one of America’s Best Companies for 2026 by TIME and Statista. The ranking evaluates firms on employee satisfaction, financial performance, and sustainability transparency. CEO Dave Li attributed the honor to the dedication of the company’s 1,400 employees.
2mo agoIngevity raises FY26 adj EPS guidance to $5.00-$5.45 vs $5.01 est
Ingevity Corporation reported Q2 adjusted EPS of $1.74, beating estimates, and raised its FY26 adjusted EPS guidance to $5.00-$5.45, surpassing the $5.01 analyst estimate. The company affirmed FY26 sales guidance of $1.05-$1.15 billion, slightly below the $1.109 billion estimate, driven by strong segment performance despite the Road Markings divestiture.
3mo agoIngevity’s Evotherm P35 secures BASt approval for warm-mix asphalt in Germany
Ingevity Corporation announced that its Evotherm P35 warm-mix additive has received approval from Germany’s Federal Highway Research Institute (BASt) for use in warm-mix asphalt applications. The approval follows years of technical evaluation and performance testing, confirming the product meets durability and long-term performance criteria for federal use in Germany. This milestone aligns with German regulatory standards and highlights Ingevity's formulation expertise in the Pavement Technologies sector.
3mo agoIngevity announces Q2 2026 earnings release and webcast
Ingevity Corporation announced it will release its second quarter 2026 earnings on July 29, 2026, after the market close. A live webcast to discuss the results is scheduled for July 30 at 10:00 a.m. (Eastern), with a recording available later that day.
4mo agoIngevity executives to speak at Wells Fargo conference
Ingevity Corporation announced that President and CEO Dave Li and CFO Phillip Platt will participate in a fireside chat at the 2026 Wells Fargo Industrials & Materials Conference on June 11. Investors can access the live webcast and subsequent replays via the company's investor relations website. Ingevity specializes in advanced carbon and engineered material solutions across three main business segments.
5mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $526.55 | +0.91% | $2,41,730.68M | 31.60 | |
| $307.86 | +0.60% | $86,344.88M | 38.49 | |
| $355.76 | +0.12% | $85,947.35M | 31.78 | |
| $315.18 | +0.94% | $70,186.17M | - | |
| $124.97 | +0.44% | $27,605.87M | 16.41 | |
| $32.54 | +3.37% | $23,555.12M | - | |
| $82.65 | -0.63% | $20,694.82M | 87.08 | |
| $155.61 | -0.81% | $20,623.30M | 36.82 | |
| $62.58 | +3.27% | $20,228.48M | - | |
| $105.78 | -0.05% | $13,490.55M | 20.63 | |
| $95.97 | +1.10% | $11,325.42M | 508.74 | |
| $67.15 | +3.28% | $10,556.72M | 48.15 |
An investment of $100 made 5 years ago in Ingevity is now worth
$ 75.75
Resulting in a loss of
$ 24.25 (24.25%)
Note: Past profits do not guarantee future returns.
